Jane Street’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
AC
GAM
BC
CS
TWA
Jane Street's AXDX Position: Q1 2025 in Review
Jane Street sold out of Accelerate Diagnostics (AXDX) in Q1 2025, closing a stake of 22,415 shares — an estimated $26.9K sold.
Jane Street first reported a position in AXDX in Q2 2013 and held it in 13 quarters. The position peaked at $3.5M in Q4 2017. 43 funds tracked by Wall St. Rank hold AXDX as of Q1 2025.
- Jane Street reported no remaining Accelerate Diagnostics position as of Q1 2025 after selling out during the quarter.
- Jane Street sold 22,415 Accelerate Diagnostics shares in Q1 2025, an estimated $26.9K.
- Jane Street first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 13 quarters.
- Jane Street's Accelerate Diagnostics position peaked at $3.5M in Q4 2017.
- 43 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2025.
Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.